EATG » Position Paper on HIV Prevention
Newsletter / News bulletin
Latest news
ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
Priority review voucher used with NDA submission with anticipated target action date of six months London, UK 17 October 2018 – ViiV Healthcare today announced it has submitted a New…
Read moreStudies confirm long-term effectiveness of new single-tablet regimens
The newest once-daily, all-in-one HIV combination pills can maintain undetectable viral load for two years and counting, according to a set of studies presented at IDWeek 2018 this month in…
Read moreIntegrated support intervention improves engagement with HIV and methadone treatment among people who inject drugs
Fewer new HIV infections among injecting partners Providing information on how to navigate care pathways, psychosocial support, and immediate antiretroviral therapy (ART) to HIV-positive people who inject drugs in Ukraine,…
Read moreLatest projects
EFOEUPATI – Ensuring the future of EUPATI beyond 2020
Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for…
PARADIGM – Patients Active in Research and Dialogues for an Improved Generation of Medicines
Project aims: To provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development of medicinal products: (i) the research priority…
HIV Outcomes – Beyond Viral Suppression
Initiative aims: HIV Outcomes, is a multi-stakeholder initiative developing and communicating expert, evidence based consensus recommendations for policy makers focused on the provision and delivery of high quality of care…
